Selected research
Market Analysis & Forecast
Global Glucokinase Market Analysis and Forecast 2026-2032
Market perspective
The global Glucokinase market is projected to grow from US$ million in 2026 to US$ million by 2032, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.
The US & Canada market for Glucokinase is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.
Europe market for Glucokinase is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.
Read the full market overview
Asia-Pacific market for Glucokinase is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.
The China market for Glucokinase is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.
The major global manufacturers of Glucokinase include Amgen Inc, Eli Lilly and Co, Ligand Pharmaceuticals Inc, Merck & Co Inc, Poxel SA, Teijin Pharma Ltd, vTv Therapeutics Inc and Yuhan Corp, etc. In 2025, the world's top three vendors accounted for approximately % of the revenue.
This report presents an overview of global market for Glucokinase, sales, revenue and price. Analyses of the global market trends, with historic market revenue or sales data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.
This report researches the key producers of Glucokinase, also provides the sales of main regions and countries. Of the upcoming market potential for Glucokinase, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the Glucokinase sales, revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global Glucokinase market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This report analyzes the segments data by Type and by Application, sales, revenue, and price, from 2021 to 2032. Evaluation and forecast the market size for Glucokinase sales, projected growth trends, production technology, application and end-user industry.
Glucokinase Segment by Company
Amgen Inc
Eli Lilly and Co
Ligand Pharmaceuticals Inc
Merck & Co Inc
Poxel SA
Teijin Pharma Ltd
vTv Therapeutics Inc
Yuhan Corp
Glucokinase Segment by Type
LY-2608204
Sinogliatin
AM-9514
TMG-123
TTP-399
Others
Glucokinase Segment by Application
Metabolic Disorder
Obesity
Diabetes
Others
Glucokinase Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Study Objectives
1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.
2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify significant trends, drivers, influence factors in global and regions.
6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Glucokinase market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Glucokinase and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Glucokinase.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type and by application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Sales (consumption), revenue of Glucokinase in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 4: Detailed analysis of Glucokinase manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 5: Provides the analysis of various market segments by type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 6: Provides the analysis of various market segments by application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 7: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Glucokinase sales, revenue, price, gross margin, and recent development, etc.
Chapter 8: North America by type, by application and by country, sales, and revenue for each segment.
Chapter 9: Europe by type, by application and by country, sales, and revenue for each segment.
Chapter 10: China type, by application, sales, and revenue for each segment.
Chapter 11: Asia (excluding China) type, by application and by region, sales, and revenue for each segment.
Chapter 12: South America, Middle East and Africa by type, by application and by country, sales, and revenue for each segment.
Chapter 13: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.
Chapter 14: The main concluding insights of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- LY-2608204
- Sinogliatin
- AM-9514
- TMG-123
- TTP-399
- Others
Applications
- Metabolic Disorder
- Obesity
- Diabetes
- Others
Companies covered
- Amgen Inc
- Eli Lilly and Co
- Ligand Pharmaceuticals Inc
- Merck & Co Inc
- Poxel SA
- Teijin Pharma Ltd
- vTv Therapeutics Inc
- Yuhan Corp
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Glucokinase Market by Type
- 1.2.1 Global Glucokinase Market Size by Type, 2021 VS 2025 VS 2032
- 1.2.2 LY-2608204
- 1.2.3 Sinogliatin
- 1.2.4 AM-9514
- 1.2.5 TMG-123
- 1.2.6 TTP-399
- 1.2.7 Others
- 1.3 Glucokinase Market by Application
- 1.3.1 Global Glucokinase Market Size by Application, 2021 VS 2025 VS 2032
- 1.3.2 Metabolic Disorder
- 1.3.3 Obesity
- 1.3.4 Diabetes
- 1.3.5 Others
- 1.4 Assumptions and Limitations
- 1.5 Study Goals and Objectives
2 Glucokinase Market Dynamics
- 2.1 Glucokinase Industry Trends
- 2.2 Glucokinase Industry Drivers
- 2.3 Glucokinase Industry Opportunities and Challenges
- 2.4 Glucokinase Industry Restraints
3 Global Market Growth Prospects
- 3.1 Global Glucokinase Revenue Estimates and Forecasts (2021-2032)
- 3.2 Global Glucokinase Revenue by Region
- 3.2.1 Global Glucokinase Revenue by Region: 2021 VS 2025 VS 2032
- 3.2.2 Global Glucokinase Revenue by Region (2021-2026)
- 3.2.3 Global Glucokinase Revenue by Region (2027-2032)
- 3.2.4 Global Glucokinase Revenue Market Share by Region (2021-2032)
- 3.3 Global Glucokinase Sales Estimates and Forecasts 2021-2032
- 3.4 Global Glucokinase Sales by Region
- 3.4.1 Global Glucokinase Sales by Region: 2021 VS 2025 VS 2032
- 3.4.2 Global Glucokinase Sales by Region (2021-2026)
- 3.4.3 Global Glucokinase Sales by Region (2027-2032)
- 3.4.4 Global Glucokinase Sales Market Share by Region (2021-2032)
- 3.5 US & Canada & Mexico
- 3.6 Europe
- 3.7 China
- 3.8 Asia (Excluding China)
- 3.9 South America, Middle East and Africa
4 Market Competitive Landscape by Manufacturers
- 4.1 Global Glucokinase Revenue by Manufacturers
- 4.1.1 Global Glucokinase Revenue by Manufacturers (2021-2026)
- 4.1.2 Global Glucokinase Revenue Market Share by Manufacturers (2021-2026)
- 4.1.3 Global Glucokinase Manufacturers Revenue Share Top 10 and Top 5 in 2025
- 4.2 Global Glucokinase Sales by Manufacturers
- 4.2.1 Global Glucokinase Sales by Manufacturers (2021-2026)
- 4.2.2 Global Glucokinase Sales Market Share by Manufacturers (2021-2026)
- 4.2.3 Global Glucokinase Manufacturers Sales Share Top 10 and Top 5 in 2025
- 4.3 Global Glucokinase Sales Price by Manufacturers (2021-2026)
- 4.4 Global Glucokinase Key Manufacturers Ranking, 2024 VS 2025 VS 2026
- 4.5 Global Glucokinase Key Manufacturers Manufacturing Sites & Headquarters
- 4.6 Global Glucokinase Manufacturers, Product Type & Application
- 4.7 Global Glucokinase Manufacturers' Establishment Date
- 4.8 Market Competitive Analysis
- 4.8.1 Global Glucokinase Market CR5 and HHI
- 4.8.2 2025 Glucokinase Tier 1, Tier 2, and Tier 3
5 Glucokinase Market by Type
- 5.1 Global Glucokinase Revenue by Type
- 5.1.1 Global Glucokinase Revenue by Type (2021 VS 2025 VS 2032)
- 5.1.2 Global Glucokinase Revenue by Type (2021-2032) & (US$ Million)
- 5.1.3 Global Glucokinase Revenue Market Share by Type (2021-2032)
- 5.2 Global Glucokinase Sales by Type
- 5.2.1 Global Glucokinase Sales by Type (2021 VS 2025 VS 2032)
- 5.2.2 Global Glucokinase Sales by Type (2021-2032) & (kt)
- 5.2.3 Global Glucokinase Sales Market Share by Type (2021-2032)
- 5.3 Global Glucokinase Price by Type
6 Glucokinase Market by Application
- 6.1 Global Glucokinase Revenue by Application
- 6.1.1 Global Glucokinase Revenue by Application (2021 VS 2025 VS 2032)
- 6.1.2 Global Glucokinase Revenue by Application (2021-2032) & (US$ Million)
- 6.1.3 Global Glucokinase Revenue Market Share by Application (2021-2032)
- 6.2 Global Glucokinase Sales by Application
- 6.2.1 Global Glucokinase Sales by Application (2021 VS 2025 VS 2032)
- 6.2.2 Global Glucokinase Sales by Application (2021-2032) & (kt)
- 6.2.3 Global Glucokinase Sales Market Share by Application (2021-2032)
- 6.3 Global Glucokinase Price by Application
7 Company Profiles
- 7.1 Amgen Inc
- 7.1.1 Amgen Inc Company Information
- 7.1.2 Amgen Inc Business Overview
- 7.1.3 Amgen Inc Glucokinase Sales, Revenue, Price and Gross Margin (2021-2026)
- 7.1.4 Amgen Inc Glucokinase Product Portfolio
- 7.1.5 Amgen Inc Recent Developments
- 7.2 Eli Lilly and Co
- 7.2.1 Eli Lilly and Co Company Information
- 7.2.2 Eli Lilly and Co Business Overview
- 7.2.3 Eli Lilly and Co Glucokinase Sales, Revenue, Price and Gross Margin (2021-2026)
- 7.2.4 Eli Lilly and Co Glucokinase Product Portfolio
- 7.2.5 Eli Lilly and Co Recent Developments
- 7.3 Ligand Pharmaceuticals Inc
- 7.3.1 Ligand Pharmaceuticals Inc Company Information
- 7.3.2 Ligand Pharmaceuticals Inc Business Overview
- 7.3.3 Ligand Pharmaceuticals Inc Glucokinase Sales, Revenue, Price and Gross Margin (2021-2026)
- 7.3.4 Ligand Pharmaceuticals Inc Glucokinase Product Portfolio
- 7.3.5 Ligand Pharmaceuticals Inc Recent Developments
- 7.4 Merck & Co Inc
- 7.4.1 Merck & Co Inc Company Information
- 7.4.2 Merck & Co Inc Business Overview
- 7.4.3 Merck & Co Inc Glucokinase Sales, Revenue, Price and Gross Margin (2021-2026)
- 7.4.4 Merck & Co Inc Glucokinase Product Portfolio
- 7.4.5 Merck & Co Inc Recent Developments
- 7.5 Poxel SA
- 7.5.1 Poxel SA Company Information
- 7.5.2 Poxel SA Business Overview
- 7.5.3 Poxel SA Glucokinase Sales, Revenue, Price and Gross Margin (2021-2026)
- 7.5.4 Poxel SA Glucokinase Product Portfolio
- 7.5.5 Poxel SA Recent Developments
- 7.6 Teijin Pharma Ltd
- 7.6.1 Teijin Pharma Ltd Company Information
- 7.6.2 Teijin Pharma Ltd Business Overview
- 7.6.3 Teijin Pharma Ltd Glucokinase Sales, Revenue, Price and Gross Margin (2021-2026)
- 7.6.4 Teijin Pharma Ltd Glucokinase Product Portfolio
- 7.6.5 Teijin Pharma Ltd Recent Developments
- 7.7 vTv Therapeutics Inc
- 7.7.1 vTv Therapeutics Inc Company Information
- 7.7.2 vTv Therapeutics Inc Business Overview
- 7.7.3 vTv Therapeutics Inc Glucokinase Sales, Revenue, Price and Gross Margin (2021-2026)
- 7.7.4 vTv Therapeutics Inc Glucokinase Product Portfolio
- 7.7.5 vTv Therapeutics Inc Recent Developments
- 7.8 Yuhan Corp
- 7.8.1 Yuhan Corp Company Information
- 7.8.2 Yuhan Corp Business Overview
- 7.8.3 Yuhan Corp Glucokinase Sales, Revenue, Price and Gross Margin (2021-2026)
- 7.8.4 Yuhan Corp Glucokinase Product Portfolio
- 7.8.5 Yuhan Corp Recent Developments
8 North America
- 8.1 North America Glucokinase Market Size by Type
- 8.1.1 North America Glucokinase Revenue by Type (2021-2032)
- 8.1.2 North America Glucokinase Sales by Type (2021-2032)
- 8.1.3 North America Glucokinase Price by Type (2021-2032)
- 8.2 North America Glucokinase Market Size by Application
- 8.2.1 North America Glucokinase Revenue by Application (2021-2032)
- 8.2.2 North America Glucokinase Sales by Application (2021-2032)
- 8.2.3 North America Glucokinase Price by Application (2021-2032)
- 8.3 North America Glucokinase Market Size by Country
- 8.3.1 North America Glucokinase Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
- 8.3.2 North America Glucokinase Sales by Country (2021 VS 2025 VS 2032)
- 8.3.3 North America Glucokinase Price by Country (2021-2032)
- 8.3.4 United States
- 8.3.5 Canada
- 8.3.6 Mexico
9 Europe
- 9.1 Europe Glucokinase Market Size by Type
- 9.1.1 Europe Glucokinase Revenue by Type (2021-2032)
- 9.1.2 Europe Glucokinase Sales by Type (2021-2032)
- 9.1.3 Europe Glucokinase Price by Type (2021-2032)
- 9.2 Europe Glucokinase Market Size by Application
- 9.2.1 Europe Glucokinase Revenue by Application (2021-2032)
- 9.2.2 Europe Glucokinase Sales by Application (2021-2032)
- 9.2.3 Europe Glucokinase Price by Application (2021-2032)
- 9.3 Europe Glucokinase Market Size by Country
- 9.3.1 Europe Glucokinase Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
- 9.3.2 Europe Glucokinase Sales by Country (2021 VS 2025 VS 2032)
- 9.3.3 Europe Glucokinase Price by Country (2021-2032)
- 9.3.4 Germany
- 9.3.5 France
- 9.3.6 U.K.
- 9.3.7 Italy
- 9.3.8 Russia
- 9.3.9 Spain
- 9.3.10 Netherlands
10 China
- 10.1 China Glucokinase Market Size by Type
- 10.1.1 China Glucokinase Revenue by Type (2021-2032)
- 10.1.2 China Glucokinase Sales by Type (2021-2032)
- 10.1.3 China Glucokinase Price by Type (2021-2032)
- 10.2 China Glucokinase Market Size by Application
- 10.2.1 China Glucokinase Revenue by Application (2021-2032)
- 10.2.2 China Glucokinase Sales by Application (2021-2032)
- 10.2.3 China Glucokinase Price by Application (2021-2032)
11 Asia (Excluding China)
- 11.1 Asia Glucokinase Market Size by Type
- 11.1.1 Asia Glucokinase Revenue by Type (2021-2032)
- 11.1.2 Asia Glucokinase Sales by Type (2021-2032)
- 11.1.3 Asia Glucokinase Price by Type (2021-2032)
- 11.2 Asia Glucokinase Market Size by Application
- 11.2.1 Asia Glucokinase Revenue by Application (2021-2032)
- 11.2.2 Asia Glucokinase Sales by Application (2021-2032)
- 11.2.3 Asia Glucokinase Price by Application (2021-2032)
- 11.3 Asia Glucokinase Market Size by Country
- 11.3.1 Asia Glucokinase Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
- 11.3.2 Asia Glucokinase Sales by Country (2021 VS 2025 VS 2032)
- 11.3.3 Asia Glucokinase Price by Country (2021-2032)
- 11.3.4 Japan
- 11.3.5 South Korea
- 11.3.6 India
- 11.3.7 Australia
- 11.3.8 Taiwan
- 11.3.9 Southeast Asia
12 South America, Middle East and Africa
- 12.1 SAMEA Glucokinase Market Size by Type
- 12.1.1 SAMEA Glucokinase Revenue by Type (2021-2032)
- 12.1.2 SAMEA Glucokinase Sales by Type (2021-2032)
- 12.1.3 SAMEA Glucokinase Price by Type (2021-2032)
- 12.2 SAMEA Glucokinase Market Size by Application
- 12.2.1 SAMEA Glucokinase Revenue by Application (2021-2032)
- 12.2.2 SAMEA Glucokinase Sales by Application (2021-2032)
- 12.2.3 SAMEA Glucokinase Price by Application (2021-2032)
- 12.3 SAMEA Glucokinase Market Size by Country
- 12.3.1 SAMEA Glucokinase Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
- 12.3.2 SAMEA Glucokinase Sales by Country (2021 VS 2025 VS 2032)
- 12.3.3 SAMEA Glucokinase Price by Country (2021-2032)
- 12.3.4 Brazil
- 12.3.5 Argentina
- 12.3.6 Chile
- 12.3.7 Colombia
- 12.3.8 Peru
- 12.3.9 Saudi Arabia
- 12.3.10 Israel
- 12.3.11 UAE
- 12.3.12 Turkey
- 12.3.13 Iran
- 12.3.14 Egypt
13 Value Chain and Sales Channels Analysis
- 13.1 Glucokinase Value Chain Analysis
- 13.1.1 Glucokinase Key Raw Materials
- 13.1.2 Raw Materials Key Suppliers
- 13.1.3 Manufacturing Cost Structure
- 13.1.4 Glucokinase Production Mode & Process
- 13.2 Glucokinase Sales Channels Analysis
- 13.2.1 Direct Comparison with Distribution Share
- 13.2.2 Glucokinase Distributors
- 13.2.3 Glucokinase Customers
14 Concluding Insights
15 Appendix
- 15.1 Reasons for Doing This Study
- 15.2 Research Methodology
- 15.3 Research Process
- 15.4 Authors List of This Report
- 15.5 Data Source
- 15.5.1 Secondary Sources
- 15.5.2 Primary Sources
- 15.6 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst